462
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Canagliflozin treatment of Hispanic and non-Hispanic patients with type 2 diabetes in a US managed care setting

, , , &
Pages 13-22 | Accepted 22 Sep 2015, Published online: 27 Oct 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Mikkel Zola Andersen, Siv Fonnes & Jacob Rosenberg. (2021) Time from submission to publication varied widely for biomedical journals: a systematic review. Current Medical Research and Opinion 37:6, pages 985-993.
Read now
Susan C Bolge, Natalia M Flores, Shu Huang & Jennifer Cai. (2017) Health care provider experience with canagliflozin in real-world clinical practice: favorability, treatment patterns, and patient outcomes. International Journal of General Medicine 10, pages 177-187.
Read now
Jennifer Cai, Victoria Divino & Chakkarin Burudpakdee. (2017) Adherence and persistence in patients with type 2 diabetes mellitus newly initiating canagliflozin, dapagliflozin, dpp-4s, or glp-1s in the United States. Current Medical Research and Opinion 33:7, pages 1317-1328.
Read now

Articles from other publishers (2)

Richard Ofori‐Asenso, Berhe W. Sahle, Ken Lee Chin, Mohsen Mazidi, Zanfina Ademi, Marie Louise De Bruin & Danny Liew. (2020) Poor adherence and persistence to sodium glucose co‐transporter 2 inhibitors in real‐world settings: Evidence from a systematic review and meta‐analysis. Diabetes/Metabolism Research and Reviews 37:1.
Crossref
John S. Mulvahill & Lenise Cummings-Vaughn. 2017. Ethnogeriatrics. Ethnogeriatrics 115 144 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.